Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;88(1051):20150071.
doi: 10.1259/bjr.20150071. Epub 2015 Mar 31.

Regional radiotherapy in high-risk breast cancer: is the issue solved?

Affiliations

Regional radiotherapy in high-risk breast cancer: is the issue solved?

M Krause et al. Br J Radiol. 2015 Jul.

Abstract

Adjuvant radiotherapy is the treatment standard for breast cancer with lymph node metastases after breast-conserving surgery or mastectomy. The inclusion of regional lymph nodes into the treatment volumes has been a question in recent clinical trials. Their impact on treatment standards and open questions is discussed.

PubMed Disclaimer

References

    1. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 2007; 82: 247–53. doi: 10.1016/j.radonc.2007.02.001 - DOI - PubMed
    1. EBCTCG (Early Breast Cancer Trialists' Collaborative Group); McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. . Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014; 383: 2127–35. doi: 10.1016/S0140-6736(14)60488-8 - DOI - PMC - PubMed
    1. Whelan T, Olivotto I, Ackerman I, Chapman JW, Chua B, Nabid A, et al. . NCIC-CTG MA.20: an intergroup trial of regional nodal irradiation in early breast cancer. ASCO Annual Meeting Abstracts Part 1. J Clin Oncol 2011; 29(Suppl): LBA1003.
    1. Poortmans P, Struikmans H, Collette S, Kirkove C, Budach V, Maingon P, et al. . Lymph node RT improves survival in breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925. In: ESTRO 33 Annual Meeting; 4–8 April 2014; Vienna, Austria. Radiother Oncol 2014. p. 215–16.
    1. Thorsen LBJ, Berg M, Brodersen HJ, Dano H, Jensen I, Overgaard J, et al. . Improved survival with internal mammary node irradiation: a prospective study on 3,072 breast cancer patients. In: ESTRO 33 Annual Meeting; 4–8 April 2014; Vienna, Austria. Radiother Oncol 2014; 111: 67–8.